RSV IMMUNISATION
Clinical trials for RSV IMMUNISATION explained in plain language.
Never miss a new study
Get alerted when new RSV IMMUNISATION trials appear
Sign up with your email to follow new studies for RSV IMMUNISATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
RSV vaccine trial for young children halted
⭐️ VACCINE ⭐️ TerminatedThis study tested a nasal spray vaccine to protect infants and toddlers (6 to 22 months old) from RSV, a common virus that can cause serious breathing problems. About 6300 healthy children were to receive either the vaccine or a placebo. The trial was terminated, so results are n…
Matched conditions: RSV IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 12:03 UTC
-
RSV vaccine study for kids: lower dose may work just as well
⭐️ VACCINE ⭐️ TerminatedThis study tested a respiratory syncytial virus (RSV) vaccine in healthy infants and toddlers aged 6 to 22 months. The goal was to see if a lower dose of the vaccine triggers a similar immune response as the standard dose, and to check the safety of different doses. The vaccine w…
Matched conditions: RSV IMMUNISATION
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 11, 2026 20:50 UTC